Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy

Head and Neck

Volumn 36, Issue 1, 2014, Pages

  Soper, Margaret S ^a   Iganej, Shawn ^a   Thompson, Lester D R ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b WOODLAND HILLS MEDICAL CENTER   (United States)

Author keywords

androgen deprivation therapy; androgen receptor; radiation; salivary duct carcinoma; salivary gland

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; LEUPRORELIN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; METASTASIS; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; SALIVARY GLAND DUCT CARCINOMA;

ANDROGEN DEPRIVATION THERAPY; ANDROGEN RECEPTOR; RADIATION; SALIVARY DUCT CARCINOMA; SALIVARY GLAND;

AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUPROLIDE; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NITRILES; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY, INTENSITY-MODULATED; RECEPTORS, ANDROGEN; SALIVARY GLAND NEOPLASMS; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 84890435901     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23383     Document Type: Article

References (9)

1. Fan CY, Wang J, Barnes EL,. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 2000; 24: 579-586.
2. Locati LD, Perrone F, Losa M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol 2009; 45: 986-990.
3. Jaspers HC, Verbist BM, Schoffelen R, et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J Clin Oncol 2011; 29: e473-e476.
4. Terhaard CHJ,. Salivary glands. In:, Halperin EC, Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology, Fifth Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. pp 874-879.
5. Everson JW,. Malignant neoplasms of the salivary glands. In:, Thompson LDR, Goldblum JR, editor. Head and Neck Pathology. Philadelphia, PA: Churchill Livingstone Elsevier; 2006. pp 354-357.
6. Laurie SA, Licitra L,. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006; 24: 2673-2678.
7. Laramore GE, Krall JM, Griffin TW, et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 1993; 27: 235-240.
8. Locati LD, Bossi B, Rinaldi GR, et al. Anti-androgen therapy in recurrent and/or metastatic salivary glands carcinoma (RSGC). Available at: http://annonc.oxfordjournals.org/content/16/suppl-3/iii38.full.pdf. Abstract #P.404. Accessed May 31, 2013.
9. Roach M III, Bae K, Speight J, et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol 2008; 26: 585-591.